Free Trial

Sarepta Therapeutics (SRPT) Earnings Date, Estimates & Call Transcripts

→ “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad)
Free srpt Stock Alerts
$127.39
+3.14 (+2.53%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 1
After Market Closes
Confirmed
Actual EPS
(Feb. 28)
$0.47 Beat By $0.50
Consensus EPS
(Feb. 28)
-$0.03
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

SRPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SRPT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sarepta Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243($0.55)$0.17($0.23) 
Q2 20244($0.58)$0.88$0.20 
Q3 20244$0.30$1.24$0.84 
Q4 20244$0.39$4.02$2.04 
FY 202415($0.44)$6.31$2.84 
Q1 20251$0.59$0.59$0.59 
Q2 20251$0.99$0.99$0.99 
Q3 20251$1.48$1.48$1.48 
Q4 20251$1.94$1.94$1.94 
FY 20254$5.00$5.00$5.00 
Q1 20261$2.01$2.01$2.01 

SRPT Earnings Date and Information

Sarepta Therapeutics last announced its earnings data on February 28th, 2024. The biotechnology company reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.50. The business earned $396.80 million during the quarter, compared to analyst estimates of $387.18 million. Its revenue for the quarter was up 53.6% on a year-over-year basis. Sarepta Therapeutics has generated ($6.12) earnings per share over the last year (($6.12) diluted earnings per share). Earnings for Sarepta Therapeutics are expected to grow by 224.41% in the coming year, from $2.13 to $6.91 per share. Sarepta Therapeutics has confirmed that its next quarterly earnings report will be published on Wednesday, May 1st, 2024. Sarepta Therapeutics will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Sarepta Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Confirmed)		-------  
2/28/2024Q4 2023($0.03)$0.47+$0.50$0.47$387.18 million$396.80 million    
11/1/2023Q3 2023($1.63)$0.37+$2.00($0.46)$285.33 million$331.80 million    
8/2/2023Q2 2023($1.89)($0.27)+$1.62($0.27)$255.99 million$261.20 million    
5/2/2023Q1 2023($1.46)($0.97)+$0.49$2.98$241.47 million$253.50 million    
2/28/2023Q4 2022($1.28)($1.24)+$0.04($1.24)$250.51 million$258.43 million    
11/2/2022Q3 2022($1.21)($2.94)($1.73)($2.94)$234.55 million$230.30 million    
8/2/2022Q2 2022($1.07)($2.65)($1.58)($2.65)$220.08 million$233.49 million
5/4/2022Q1 2022($1.35)($1.20)+$0.15($1.20)$208.25 million$210.83 million    
3/1/2022Q4 2021($1.51)($1.42)+$0.09($1.42)$198.48 million$201.50 million    
11/3/2021Q3 2021($1.86)($0.60)+$1.26($0.60)$170.13 million$189.41 million    
8/4/2021Q2 2021($1.29)($1.02)+$0.27($1.02)$161.95 million$164.09 million    
5/5/2021Q1 2021($2.01)($2.10)($0.09)($2.10)$140.73 million$146.93 million  

Sarepta Therapeutics Earnings - Frequently Asked Questions

When is Sarepta Therapeutics's earnings date?

Sarepta Therapeutics has confirmed that its next quarterly earnings data will be published on Wednesday, May 1st, 2024. Learn more on SRPT's earnings history.

Did Sarepta Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Sarepta Therapeutics (NASDAQ:SRPT) reported $0.47 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.03) by $0.50. Learn more on analysts' earnings estimate vs. SRPT's actual earnings.

How can I listen to Sarepta Therapeutics's earnings conference call?

The conference call for Sarepta Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Sarepta Therapeutics's conference call transcript?

The conference call transcript for Sarepta Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Sarepta Therapeutics generate each year?

Sarepta Therapeutics (NASDAQ:SRPT) has a recorded annual revenue of $1.24 billion.

How much profit does Sarepta Therapeutics generate each year?

Sarepta Therapeutics (NASDAQ:SRPT) has a recorded net income of -$535.98 million. SRPT has generated -$6.12 earnings per share over the last four quarters.

What is Sarepta Therapeutics's EPS forecast for next year?

Sarepta Therapeutics's earnings are expected to grow from $2.13 per share to $6.91 per share in the next year, which is a 224.41% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:SRPT) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings